GSK will invest up to £50 million in the new project, which could inform future development of cancer vaccines.

Scientists at Oxford University, which pioneered Covid-19 vaccines, turn attention to ‘detecting the undetectable’ and ...

GSK and the University of Oxford have entered a new research partnership to launch an immuno-prevention programme to explore ...

Scientists at Oxford University and drugmaker GSK to ‘detect the undetectable’ and identify changes in cells that start up to ...

Cancer vaccine being created by UK scientists could stop disease up to 20 years early - A new partnership between the ...

The partnership between the pharmaceutical giant and the university aims to create a vaccine or vaccines which target cells ...

The pharma group has pledged up to £50 million ($62.5 million) in funding over three years for the initiative, which builds ...

British pharma giant GSK is heading back to school, pledging up to 50 million pounds sterling (about $62.4 million) to work ...

Oxford University and pharmaceutical giant GSK are creating a new cancer vaccine to prevent the disease from developing. The partnership intends to create a vaccine or vaccines which target cells at ...

The Oxford Vaccine Group is set to send five healthy people to the Netherlands to be infected with a form of malaria to allow ...

Pro-vaccine activism is set to be explored in a new book written by a University of Oxford professor. Professor Samantha Vanderslott's book, Pro-vax, aims to redefine how people think about ...

Oxford University is hoping to create a vaccine to stop the disease 20 years before it develops, as part of a joint project ...